Side-by-side comparison of AI visibility scores, market position, and capabilities
Home fitness streaming platform behind P90X and Insanity; BODi subscription competing with Peloton and Apple Fitness+ after pivoting away from MLM coach distribution model.
Beachbody is a direct-to-consumer home fitness company known for producing iconic workout programs (P90X, Insanity, 21 Day Fix, T25, LIIFT4) delivered through its Beachbody On Demand subscription streaming service, alongside nutritional supplement products under the Shakeology brand. Founded in 1998 in Santa Monica, California by Carl Daikeler and Jon Congdon, Beachbody went public via SPAC in 2021 under BODi (NYSE: BODY), but the public market journey was difficult — the company underwent significant restructuring and moved away from its multi-level marketing coach network in favor of direct digital marketing.\n\nBeachbody's workout programs are structured multi-week fitness plans (P90X is a 90-day extreme home workout program) delivered as streaming video workouts through the Beachbody On Demand platform, with subscription access to the full program library. The company's pivot from the trainer/coach MLM distribution model to digital direct-to-consumer subscription reflected broader changes in how fitness content is discovered and purchased. Shakeology, the protein shake and meal replacement supplement, generates significant recurring revenue from loyal customers who subscribe to monthly delivery.\n\nIn 2025, Beachbody/BODi operates in the competitive digital fitness market with Peloton (equipment + content), Nike Training Club (free), Apple Fitness+, and Les Mills On Demand for streaming workout subscription market share. The home fitness market experienced a COVID boom in 2020-2021 followed by significant normalization as gyms reopened — Peloton faced severe financial difficulties and Beachbody's public market valuation declined substantially. The 2025 strategy focuses on the BODi subscription service as the core product, simplifying the coach/affiliate program that defined the old model, and growing through digital acquisition rather than MLM-style recruitment, competing on program quality and community.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.